Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06408688
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-20
First Post:
2024-05-07
Brief Title:
Safety and Modulation of Adaptive Immunity by Iscador Qu Viscum Album Extract in Patients With Advanced Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors
Sponsor:
University Hospital Basel Switzerland
Organization:
University Hospital Basel Switzerland
Organization Data
Organization:
University Hospital Basel Switzerland
Class:
OTHER
Study ID:
2023-02373 th23binder
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Basel Switzerland
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None